The focus of the study by Alagappa University and KTH Royal Institute of Technology was to find drugs that can target vital proteins of the novel Coronavirus.
FDA said Pfizer's vaccine trial data show that side effects are common, and there are no specific safety concerns that would preclude the issuance of EUA.
Teams from the World Health Organization, Indian Council of Medical Research and All India Institute of Medical Sciences are examining the cause of the mystery illness